Literature DB >> 6758825

The effect of propranolol on luteinising hormone and prolactin plasma concentrations in hypertensive women.

A M Dart, K McHardy, H E Barber.   

Abstract

1 Chronic propranolol treatment has been previously shown to lower the plasma concentrations of LH and prolactin in normal male volunteers. 2 The effect of 2 weeks treatment with propranolol (80 mg twice daily) on the plasma concentrations of LH and prolactin has now been investigated in five post menopausal hypertensive women. 3 There was no significant effect of propranolol treatment on the basal plasma concentrations of either hormone. Both hormones showed significant increases in plasma concentration following GnRH stimulation and these increases were also unaffected by propranolol treatment.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6758825      PMCID: PMC1427554          DOI: 10.1111/j.1365-2125.1982.tb02046.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  3 in total

1.  Sleep-related, nychthermeral and briefly episodic variation in human plasma prolactin concentrations.

Authors:  D C Parker; L G Rossman; E F Vander Laan
Journal:  J Clin Endocrinol Metab       Date:  1973-06       Impact factor: 5.958

2.  The effect of chronic propranolol treatment on overnight plasma levels of anterior pituitary and related hormones.

Authors:  A M Dart; M J Lewis; G V Groom; E M Meek; A H Henderson
Journal:  Br J Clin Pharmacol       Date:  1981-12       Impact factor: 4.335

3.  Simultaneous pulsatile release of prolactin and luteinizing hormone induced by luteinizing hormone-releasing factor agonist.

Authors:  R F Casper; S S Yen
Journal:  J Clin Endocrinol Metab       Date:  1981-05       Impact factor: 5.958

  3 in total
  1 in total

1.  Withdrawal phenomena after atenolol and bopindolol: hormonal changes in normal volunteers.

Authors:  R J Walden; B Tomlinson; B Graham; C Smith; D J Betteridge; B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1990-10       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.